Dhanvantri Jeevan Rekha Ltd
Dhanvantri Jeevan Rekha Ltd (ZDHJERK): company summary
The company's revenue grew 14.2% annually, reaching ₹26 crore, but net profit fell 21.6% to ₹0 crore.
Dhanvantri Jeevan Rekha Ltd (ZDHJERK) is a micro-cap Healthcare Services company valued at ₹10 crore operating in Healthcare Service Provider on the NSE and BSE.
- Recent price move
- Dhanvantri Jeevan Rekha Ltd last traded at ₹23.75, unchanged on the day.
- Recent developments
- On 2026-06-30, the company reported its latest quarter results, showing revenue of ₹8 crore, up 41.6% from the same quarter a year earlier. Net profit remained at ₹0 crore, unchanged from the prior quarter. The company's financials for the fiscal year ended 2026-03-31 showed a net profit of ₹0 crore, down from ₹1 crore a year earlier.
- Financial performance
- The company's revenue grew 14.2% annually, reaching ₹26 crore, but net profit fell 21.6% to ₹0 crore. In the latest quarter, revenue rose 41.6% year-on-year to ₹8 crore, while net profit remained at ₹0 crore, matching the previous quarter's figure.
- Valuation multiples
- The stock trades at 25.3 times earnings, 0.94 times book value.
- Things to watch
- The company reported an annual net profit of ₹0 crore, down 21.6% from ₹1 crore a year earlier. The net profit margin narrowed to 1.5% from 2.3% in the prior year. The latest quarter's net profit remained at ₹0 crore, despite a 41.6% rise in revenue.
- Where it stands
- The company's revenue has grown steadily, with a 13.5% CAGR over three years and 21.5% over five years, but net profit remains at ₹0 crore. The latest quarter's revenue rose 41.6% year-on-year, but net profit did not change. The stock is 20.8% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by risk (6.0), but held back by quality (2.3).
DocStoX score
Low confidenceAt a glance
Key highlights
- Low leverage — D/E 0.00
- Revenue compounding 21% a year
- Profit shrinking 8% a year
- Quality is weak (2.3/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare Services stocks · Healthcare Service Provider
Explore Dhanvantri Jeevan Rekha Ltd’s valuation
Free deep-dive tools · no sign-up
Dhanvantri Jeevan Rekha Ltd peers in Healthcare Services
Other Healthcare Services stocks on the NSE & BSE. See the full Healthcare Services sector list.
Related tools & concepts
Value Dhanvantri Jeevan Rekha Ltd with the ratios and calculators DocStoX uses in its analysis.

